Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Akebia Therapeutics, Inc. | akba-ex231_8.htm |
| EX-31.1 - EX-31.1 - Akebia Therapeutics, Inc. | akba-ex311_10.htm |
| EX-99.1 - EX-99.1 - Akebia Therapeutics, Inc. | akba-ex991_13.htm |
| EX-31.2 - EX-31.2 - Akebia Therapeutics, Inc. | akba-ex312_11.htm |
| EX-32.1 - EX-32.1 - Akebia Therapeutics, Inc. | akba-ex321_12.htm |
| EX-10.4 - EX-10.4 - Akebia Therapeutics, Inc. | akba-ex104_737.htm |
| EX-10.29 - EX-10.29 - Akebia Therapeutics, Inc. | akba-ex1029_738.htm |
| 10-K - 10-K - Akebia Therapeutics, Inc. | akba-10k_20151231.htm |
Exhibit 21.1
|
SUBSIDIARIES OF THE REGISTRANT |
||||||
|
|
|
|
|
|
|
|
|
Name |
|
|
Ownership Percentage |
|
|
Jurisdiction of Organization |
|
Akebia Therapeutics Securities Corporation |
|
|
100 |
% |
|
Massachusetts |
|
Akebia Europe Limited |
|
|
100 |
% |
|
Ireland |